Suchergebnisse - "Gulick, Roy M"

PubPharm (30)

1

ART in HIV-Positive Persons With Low Pretreatment Viremia : Results From the START Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2019

von Sereti, I. | Gulick, R. | Krishnan, S. | +7

2

Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL : week 48 outcomes from ACTG 5353

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Nyaku, A. | Zheng, L. | Gulick, R. | +19

3

ACTG A5353 : A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2018

von Taiwo, B. | Zheng, L. | Stefanescu, A. | +11

4

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

enthalten in: Nature medicine | 2017

von Caskey, M. | Schoofs, T. | Gruell, H. | +34

5

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide : an analysis of trial data

enthalten in: Annals of internal medicine | 2014

von Mollan, K. | Smurzynski, M. | Eron, J. | +8

ErratumIn: Ann Intern Med. 2014 Aug 19;161(4):308

6

Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

enthalten in: Biometrics | 2013

von Johnson, B. | Ribaudo, H. | Gulick, R. | +1

7

Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013

von Fiscus, S. | Cu-Uvin, S. | Eshete, A. | +109

8

Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay : reanalysis of AIDS clinical trials group A5211

enthalten in: The Journal of infectious diseases | 2009

von Su, Z. | Gulick, R. | Krambrink, A. | +10

9

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

enthalten in: PloS one | 2009

von Tsibris, A. | Korber, B. | Arnaout, R. | +14

10

Maraviroc for previously treated patients with R5 HIV-1 infection

enthalten in: The New England journal of medicine | 2008

von Gulick, R. | Lalezari, J. | Goodrich, J. | +116

CommentIn: N Engl J Med. 2008 Oct 2;359(14):1509-11. - PMID 18832250